A Multi-center, Randomized, Double blind, Prospective Study to Evaluate the Efficacy and Safety of high induction doses of adalimumab in moderate to severe psoriasis patients. The DEEP study.
Latest Information Update: 05 Jan 2018
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms The DEEP study
- 05 Jan 2018 This trial has been Discontinued in Spain according to European Clinical Trials Database record.
- 13 Sep 2016 New trial record